ctrl K

Price Alert

Allogene Therapeutics Inc... (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.03

-0.02 (-1.90%)

At close: Aug 20, 2025, 10:12 AM

Allogene Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	75.22M	83.16M	61.9M	173.31M
Short-Term Investments	217.26M	365.54M	455.42M	283.99M
Long-Term Investments	80.67M	3.65M	59.15M	370.18M
Other Long-Term Assets	33.39M	16.9M	32.67M	-322.05M
Receivables	1.9M	1.7M	3.3M	6M
Inventory	n/a	n/a	-62.45M	-20.02M
Other Current Assets	9.01M	n/a	62.45M	14.02M
Total Current Assets	303.39M	459.12M	528.82M	471.32M
Property-Plant & Equipment	131.26M	163.18M	196.43M	181.02M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	245.32M	183.72M	288.25M	229.15M
Total Assets	548.71M	642.84M	817.08M	1.04B
Account Payables	5.39M	5.9M	13.89M	10.26M
Deferred Revenue	n/a	86K	885K	156K
Short-Term Debt	7.51M	6.78M	6M	3.2M
Other Current Liabilities	4.64M	4.88M	9.8M	1.45M
Total Current Liabilities	35.52M	37.08M	54.52M	47.91M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	7.76M	5.18M	5.85M	7.79M
Total Long-Term Liabilities	91.01M	93.53M	100.97M	74.05M
Total Liabilities	126.53M	130.6M	151.21M	122.23M
Total Debt	90.76M	95.12M	101.12M	73.13M
Common Stock	212K	169K	144K	142K
Retained Earnings	-1.82B	-1.56B	-1.24B	-903.35M
Comprehensive Income	-89K	-955K	-9.93M	-2.57M
Shareholders Equity	422.18M	512.23M	665.87M	916.41M
Total Investments	297.93M	369.19M	514.57M	654.17M